评估房间隔分流装置在心力衰竭管理中的作用：来自RELIEVE-HF试验的见解。 - Suppr

Suppr

超能文献

Evaluating the role of interatrial shunt devices in heart failure management: insights from the RELIEVE-HF trial.

作者信息

Sideris Konstantinos, Liori Sotiria

机构信息

Division of Cardiovascular Medicine, University of Utah Health, 50 N Medical Dr, Salt Lake City, UT, 84132-0001, USA.

出版信息

Heart Fail Rev. 2024 Sep;29(5):909-912. doi: 10.1007/s10741-024-10407-9. Epub 2024 Jun 13.

DOI:10.1007/s10741-024-10407-9

PMID:38869679

Abstract

摘要

相似文献

Evaluating the role of interatrial shunt devices in heart failure management: insights from the RELIEVE-HF trial.评估房间隔分流装置在心力衰竭管理中的作用：来自RELIEVE-HF试验的见解。

Heart Fail Rev. 2024 Sep;29(5):909-912. doi: 10.1007/s10741-024-10407-9. Epub 2024 Jun 13.

Interatrial Shunt Treatment for Heart Failure: The Randomized RELIEVE-HF Trial.心房分流术治疗心力衰竭：随机对照RELIEVE-HF试验

Circulation. 2024 Dec 10;150(24):1931-1943. doi: 10.1161/CIRCULATIONAHA.124.070870. Epub 2024 Sep 23.

One-Year Safety and Clinical Outcomes of a Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure With Preserved Ejection Fraction in the Reduce Elevated Left Atrial Pressure in Patients With Heart Failure (REDUCE LAP-HF I) Trial: A Randomized Clinical Trial.经导管房间隔分流装置治疗射血分数保留心力衰竭的一年安全性和临床结局：降低心力衰竭患者左心房压力（REDUCE LAP-HF I）试验：一项随机临床试验。

JAMA Cardiol. 2018 Oct 1;3(10):968-977. doi: 10.1001/jamacardio.2018.2936.

Interatrial shunt therapy in advanced heart failure: Outcomes from the open-label cohort of the RELIEVE-HF trial.晚期心力衰竭的房间隔分流治疗：RELIEVE-HF试验开放标签队列的结果

Eur J Heart Fail. 2024 Apr;26(4):1078-1089. doi: 10.1002/ejhf.3215. Epub 2024 Apr 1.

Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure: Rationale and Design of the Randomized Trial to REDUCE Elevated Left Atrial Pressure in Heart Failure (REDUCE LAP-HF I).用于治疗心力衰竭的经导管房间隔分流装置：降低心力衰竭患者升高的左心房压力的随机试验（REDUCE LAP-HF I）的原理与设计

Circ Heart Fail. 2016 Jul;9(7). doi: 10.1161/CIRCHEARTFAILURE.116.003025.

Heart failure and atrial fibrillation in patients with an interatrial shunt.房间隔分流患者的心力衰竭和心房颤动。

Clin Res Cardiol. 2021 Aug;110(8):1270-1279. doi: 10.1007/s00392-021-01811-4. Epub 2021 Mar 1.

Atrial Shunt Device Effects on Cardiac Structure and Function in Heart Failure With Preserved Ejection Fraction: The REDUCE LAP-HF II Randomized Clinical Trial.房间隔分流装置对射血分数保留的心力衰竭患者心脏结构和功能的影响：RE- DUCELAP-HF II 随机临床试验。

JAMA Cardiol. 2024 Jun 1;9(6):507-522. doi: 10.1001/jamacardio.2024.0520.

2-Year Outcomes of an Atrial Shunt Device in HFpEF/HFmrEF: Results From REDUCE LAP-HF II.肥厚型心衰/射血分数中间值心衰患者心房分流装置的 2 年结果：来自 REDUCE LAP-HF II 的研究结果。

JACC Heart Fail. 2024 Aug;12(8):1425-1438. doi: 10.1016/j.jchf.2024.04.011. Epub 2024 Jun 26.

In vivo fluid dynamics of the Ventura interatrial shunt device in patients with heart failure.心力衰竭患者 Ventura 房间隔分流装置的体内流体动力学。

ESC Heart Fail. 2024 Oct;11(5):2499-2509. doi: 10.1002/ehf2.14859. Epub 2024 May 22.

Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure With Preserved Ejection Fraction (REDUCE LAP-HF I [Reduce Elevated Left Atrial Pressure in Patients With Heart Failure]): A Phase 2, Randomized, Sham-Controlled Trial.经导管房间隔分流装置治疗射血分数保留的心力衰竭（REDUCE LAP-HF I [降低心力衰竭患者左心房压力]）：一项 2 期、随机、假手术对照试验。

Circulation. 2018 Jan 23;137(4):364-375. doi: 10.1161/CIRCULATIONAHA.117.032094. Epub 2017 Nov 15.

本文引用的文献

Interatrial shunt therapy in advanced heart failure: Outcomes from the open-label cohort of the RELIEVE-HF trial.晚期心力衰竭的房间隔分流治疗：RELIEVE-HF试验开放标签队列的结果

Eur J Heart Fail. 2024 Apr;26(4):1078-1089. doi: 10.1002/ejhf.3215. Epub 2024 Apr 1.

Patient phenotype profiling in heart failure with preserved ejection fraction to guide therapeutic decision making. A scientific statement of the Heart Failure Association, the European Heart Rhythm Association of the European Society of Cardiology, and the European Society of Hypertension.射血分数保留的心力衰竭患者表型分析以指导治疗决策。心力衰竭协会、欧洲心脏病学会的欧洲心律协会和欧洲高血压学会的科学声明。

Eur J Heart Fail. 2023 Jul;25(7):936-955. doi: 10.1002/ejhf.2894. Epub 2023 Jul 17.

The RAISE Trial: A Novel Device and First-in-Man Trial.RAISE 试验：一种新型装置和首例人体试验。

Circ Heart Fail. 2022 Apr;15(4):e008362. doi: 10.1161/CIRCHEARTFAILURE.121.008362. Epub 2022 Apr 5.

2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure.2021年欧洲心脏病学会急性和慢性心力衰竭诊断与治疗指南。

Eur Heart J. 2021 Sep 21;42(36):3599-3726. doi: 10.1093/eurheartj/ehab368.

One-year results of the first-in-man study investigating the Atrial Flow Regulator for left atrial shunting in symptomatic heart failure patients: the PRELIEVE study.首例在有症状心力衰竭患者中左心房分流的心房血流调节剂的人体研究的一年结果：PRELIEVE 研究。

Eur J Heart Fail. 2021 May;23(5):800-810. doi: 10.1002/ejhf.2119. Epub 2021 Mar 5.

Interatrial Shunting for Heart Failure: Early and Late Results From the First-in-Human Experience With the V-Wave System.房间隔分流术治疗心力衰竭：首例 V-Wave 系统人体试验的早期和晚期结果。

JACC Cardiovasc Interv. 2018 Nov 26;11(22):2300-2310. doi: 10.1016/j.jcin.2018.07.001. Epub 2018 Nov 1.

JAMA Cardiol. 2018 Oct 1;3(10):968-977. doi: 10.1001/jamacardio.2018.2936.

One-Year Outcomes After Transcatheter Insertion of an Interatrial Shunt Device for the Management of Heart Failure With Preserved Ejection Fraction.经导管插入房间隔分流装置治疗射血分数保留的心力衰竭的一年结局

Circ Heart Fail. 2016 Dec;9(12):e003662. doi: 10.1161/CIRCHEARTFAILURE.116.003662.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验